Swiss National Bank
CELU icon

Swiss National Bank’s Celularity CELU Stock Holding History

Swiss National Bank’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,024
Closed -$155K – 2648
2022
Q4 		$155K Buy
12,024
+5,540
+85% +$102K ﹤0.01% 2673
2022
Q3 		$150K Hold
6,484
– – ﹤0.01% 2705
2022
Q2 		$220K Buy
+6,484
New +$527K ﹤0.01% 2729

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Swiss National Bank's CELU Position: Q1 2023 in Review

Swiss National Bank sold out of Celularity (CELU) in Q1 2023, closing a stake of 12,024 shares — an estimated $155K sold.

Swiss National Bank first reported a position in CELU in Q2 2022 and held it in 3 quarters. The position peaked at $220K in Q2 2022. 61 funds tracked by Wall St. Rank hold CELU as of Q1 2023.

  • Swiss National Bank reported no remaining Celularity position as of Q1 2023 after selling out during the quarter.
  • Swiss National Bank sold 12,024 Celularity shares in Q1 2023, an estimated $155K.
  • Swiss National Bank first reported a position in Celularity in Q2 2022 and held it in 3 quarters.
  • Swiss National Bank's Celularity position peaked at $220K in Q2 2022.
  • 61 funds tracked by Wall St. Rank held Celularity as of Q1 2023.

Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.